Status:

COMPLETED

Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes

Lead Sponsor:

German Diabetes Center

Collaborating Sponsors:

Heinrich-Heine University, Duesseldorf

Conditions:

Obesity

Non-insulin-dependent Diabetes Mellitus

Eligibility:

All Genders

30-70 years

Phase:

NA

Brief Summary

Hyperbaric oxygen therapy (HBO) is applied for several diseases. The effect on insulin sensitivity is yet unknown. Hypothesis: HBO therapy improves insulin sensitivity in patients.

Detailed Description

HBO therapy is applied to improve wound healing in diabetic patients with foot ulcera. However, it might induce oxidative stress as well as improve antioxidative capacity. The effects on insulin sensi...

Eligibility Criteria

Inclusion

  • Aged ≥ 30 years- ≤ 70 years
  • Balanced sex (50: 50)
  • BMI 20- 25 kg/m 2 normal- weight group
  • BMI 35- 39,9 kg/m 2 (Obese typ II)

Exclusion

  • Acute illness 2 weeks before start of examination
  • Autoimmune or Immune disorder deseases (Leukozyten \< 5000/µl
  • Renal insufficiency (Kreatin \> 1,5 mg/dl)
  • Heart disease, condition after heart attack
  • Anemia (Hb \<12g/l, contolled before every day of eximination) or blood donations 4weeks before eximinatin.
  • Participation in another trial within the last 2 weeks
  • Pharmacological- immuno therapy (Cortisol, Antihistaminika, ASS)
  • Thyroid disorders
  • Glitazone or Insulin- Therapy
  • Pragnancy, Lactation, Menstruation
  • Smoking cigaretts, Alcohol- and drug abuse
  • Psychiatric disorders
  • Risk for/ or diagnosed HIV/ AIDS or Hepatitis B/C
  • Liver disease, which are not caused by non- alcoholic steato- hepatitis
  • Working on night shifts or irregular rhythem of night- day
  • Impaired wound healing or clotting disorders
  • Allergic reaction to local anesthetics
  • Malignant cancer

Key Trial Info

Start Date :

March 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2015

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01472328

Start Date

March 1 2012

End Date

August 1 2015

Last Update

June 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

German Diabetes Center

Düsseldorf, Germany, 40225